Serum markers of myocardial fibrosis in the diagnosis of Wolff-Parkinson-White (WPW) syndrome

Автор: Kodirova G.I., Iminov Kh.M., Tashtemirova I.M., Bektashev I.B., Uktamov N.

Журнал: Экономика и социум @ekonomika-socium

Рубрика: Основной раздел

Статья в выпуске: 10 (89), 2021 года.

Бесплатный доступ

Most view Wolff-Parkinson-White (WPW) syndrome as a heart rhythm disorder. However, the actual syndrome still remains a problem in the choice of patient management tactics. Its significance is that young people of working age suffer from this pathology. Ventricular preexcitation syndromes are found in all age groups and are verified in 1-30 patients per 10,000 people. However, in most cases, the clinical manifestation of the syndrome occurs between the ages of 10 and 20, and much less frequently in the elderly. The prevalence of preexitation syndromes in the general population is approximately 0.15-0.25% and increases in combination with congenital heart defects - 0.5%. In 40-80% of patients, WPW syndrome is clinically manifested by various forms of cardiac arrhythmias (HRD).

Еще

Wolff-Parkinson-White, cardiac arrhythmias, atrial fibrillation, heart rate, effective refractory period, ventricular fibrillation, sudden cardiac death.

Короткий адрес: https://sciup.org/140260740

IDR: 140260740

Список литературы Serum markers of myocardial fibrosis in the diagnosis of Wolff-Parkinson-White (WPW) syndrome

  • Ardashev, V.N. Treatment of cardiac arrhythmias / V.N. Ardashev, A.V. Ardashev and V.I. Steklov. - M.: ID Medpraktika, 2005. - 228 p.
  • Ardashev, A.V. Wolff-Parkinson-White syndrome: classification, clinical manifestations, diagnosis and treatment / A.V. Ardashev [and others] // Cardiology. - 2009. - No.10. - P. 8494.
  • Arrhythmology: clinical guidelines for electrophysiological studies, catheter ablation and the use of implantable antiarrhythmic devices / A.Sh. Revishvili [and others] - M .: GEOTAR-Media, 2010. - 304 p.
  • Akhmedov, V.A. Metalloproteinase activity in patients with metabolic syndrome and atrial fibrillation / V.A. Akhmedov, V.T. Dolgikh, D.V. Naumov, V.E. Dvornikov // Bulletin of Novosibirsk State University. Series: Biology, Clinical Medicine. –2010. - T. 8, No. 4. - S. 113-118.
  • Bobrov V.A. Diagnostics of syndromes of premature excitation of ventricles / V.A. Bobrov [and others] // Ukr. cardiol. zhurn. - 2009. - No. 4. - S. 98-108.
  • Valikova, T.A. Neurology. Autonomic nervous system (anatomy, physiology, clinical manifestations, treatment) / T.A. Valikova, V.M. Alifirova, N.V. Pugachenko, O. V. Grebenyuk // Textbook. - Tomsk, 2013 . - P. 142.
  • Vasilets, L.M. Fibrosis markers and structural and functional parameters of the left atrium in patients with atrial fibrillation / L.M. Vasilets [et al.] // Modern problems of science and education. - 2013. - № 2. - Electronic magazine. - http://www.science-education.ru/108-9118.
  • Vatutin, N.T. Syndrome of premature excitation of the ventricles / N.T. Vatutin, N.V. Kalinkina // Syndromes in cardiology. - 2010 .- S. 146-147.
  • Hasanov, A.G. Matrix metalloproteinases and features of apoptosis in cardiomyopathies and congenital heart defects in children): author. dis. Doctor of Medical Sciences. / Hasanov A.G. - Moscow, 2010. - 49 p.
  • Genetic aspects of atrial fibrillation / V.А. Shulman [et al.] // Bulletin of arrhythmology. - 2007. - No. 47. - S. 57-60.
Еще
Статья научная